In a recent study by Aksoy et al., CRYM could be identified as a prognostic marker in prostate cancer [13]; however, a potential prognostic or therapeutic relevance of CRYM in HNSCC has not yet been investigated in detail [14]. Here, CRYM is linked to head and neck squamous cell carcinoma.